Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs FND✓SelectedUSD · FNDGSK vs FND performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs FND

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+41.1%
FND return
-64.7%
Excess return
+105.9%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioFNDExcessAlpha
1D-0.1%+1.1%-1.2%-0.2%
7D-5.3%-1.8%-3.5%-5.2%
30D-3.7%+3.9%-7.6%-4.0%
3M-7.3%-14.3%+7.0%-6.2%
6M-4.2%-0.3%-3.9%-4.5%
YTD+0.9%-23.0%+23.9%+2.2%
1Y+7.3%-18.5%+25.7%+8.2%
3Y+52.7%-48.2%+101.0%+58.4%
All+41.1%-64.7%+105.9%+47.7%

Cumulative growth

Daily Returns

Daily percentage return beside FND.

Daily Out/Under-Performance

Portfolio return minus FND return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × FND return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded FND wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling